Experimental Therapeutics

This program aims to identify ‘molecular targets’ - critical genes and proteins that contribute to the growth and malignant behaviour of cancer cells, so that therapeutic strategies can then be developed to inhibit their action, with the goal of treating the cancer more effectively

Group Leader Name
Prof Michelle Haber AM
Image
Michelle Haber

Back to top